BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21098212)

  • 1. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications.
    Loving VA; DeMartini WB; Eby PR; Gutierrez RL; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2010 Dec; 195(6):1472-7. PubMed ID: 21098212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
    Yao MM; Joe BN; Sickles EA; Lee CS
    Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
    Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
    Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does patient age affect the PPV
    Hu Y; Yang Y; Gu R; Jin L; Shen S; Liu F; Wang H; Mei J; Jiang X; Liu Q; Su F
    Eur Radiol; 2018 Jun; 28(6):2492-2498. PubMed ID: 29302783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5.
    Fu CY; Hsu HH; Yu JC; Hsu GC; Hsu KF; Chan DC; Ku CH; Lu TC; Chu CH
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S8-13. PubMed ID: 20603785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS.
    Heinig J; Witteler R; Schmitz R; Kiesel L; Steinhard J
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):573-8. PubMed ID: 18421795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observer variability of Breast Imaging Reporting and Data System (BI-RADS) for breast ultrasound.
    Lee HJ; Kim EK; Kim MJ; Youk JH; Lee JY; Kang DR; Oh KK
    Eur J Radiol; 2008 Feb; 65(2):293-8. PubMed ID: 17531417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palpable breast abnormalities in women under age 40.
    Lee MV; Shaw HL; Chi T; Brazeal HA; Holley SO; Appleton CM
    Breast J; 2018 Sep; 24(5):798-805. PubMed ID: 29687544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
    Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
    Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The negative predictive value of electrical impedance scanning in BI-RADS category IV breast lesions.
    Fuchsjaeger MH; Flöry D; Reiner CS; Rudas M; Riedl CC; Helbich TH
    Invest Radiol; 2005 Jul; 40(7):478-85. PubMed ID: 15973141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
    Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
    AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification.
    Evans A; Whelehan P; Thomson K; Brauer K; Jordan L; Purdie C; McLean D; Baker L; Vinnicombe S; Thompson A
    Br J Cancer; 2012 Jul; 107(2):224-9. PubMed ID: 22691969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does power Doppler ultrasonography improve the BI-RADS category assessment and diagnostic accuracy of solid breast lesions?
    Tozaki M; Fukuma E
    Acta Radiol; 2011 Sep; 52(7):706-10. PubMed ID: 21596798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation.
    Robbins J; Jeffries D; Roubidoux M; Helvie M
    AJR Am J Roentgenol; 2011 Mar; 196(3):716-22. PubMed ID: 21343518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of breast elastography added to the BI-RADS® (5th edition) lexicon classification.
    Fleury Ede F
    Rev Assoc Med Bras (1992); 2015 Aug; 61(4):313-6. PubMed ID: 26466211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.